New Haven-based Achillion Pharmaceuticals Inc. recently named Joel Barrish as chief scientific officer and executive vice president.
Barrish joins Achillion with more than 30 years of experience in the pharmaceutical industry. For the last five years, he was vice president and head of discovery chemistry at Bristol-Myers Squibb, leading chemical research on small molecules and other modalities across all therapeutic areas and sites.
Barrish is also a scientific advisory board member for the chemistry departments at the University of Pennsylvania and at Rutgers University.
